Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019)

Updated

Ocular Therapeutix's Long-Term Debt Issuances was $82.47 million in FY2023.

Analysis

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019) Analysis & Trends

From FY2012 onward, Ocular Therapeutix has reported Long-Term Debt Issuances for 9 years.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of 47.0% (FY2018 to FY2023).
  • The FY2023 figure marks the highest annual Long-Term Debt Issuances in data going back to FY2012.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $3.72 million in FY2021 (+16.3%), $3.2 million in FY2020 (-91.4%) and $37.28 million in FY2019 (+209.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -70,000.00
Mar 31, 2019 37.35 Mn
Mar 31, 2017 3.70 Mn
API Access

Ocular Therapeutix Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=OCUL&period=max&api_key=YOUR_API_KEY